Table 2.
Parameters | CI | Effect |
---|---|---|
In vitro antioxidant models | ||
ABTS (mg/mL) | 0.000 ± 0.000 | Synergistic |
β-carotene bleaching (mg/mL) | 3.764 ± 0.122 | Antagonistic |
Ferric reducing power (mg/mL) | 0.245 ± 0.026 | Synergistic |
Liver function parameters | ||
ALT (U/L) | 0.866 ± 0.072 | Synergistic |
AST (U/L) | 0.545 ± 0.148 | Synergistic |
ALP (U/L) | 0.626 ± 0.129 | Synergistic |
Albumin (mg/dl) | 0.893 ± 0.107 | Synergistic |
Total protein (g/dl) | 1.006 ± 0.062 | Additive |
Kidney function markers | ||
Urea (mg/dl) | 0.798 ± 0.067 | Synergistic |
Creatinine (mg/dl) | 0.725 ± 0.077 | Synergistic |
Lead concentration | ||
Blood lead level (μg/dl) | 0.037 ± 0.012 | Synergistic |
Hepatic lead Level (μg/g tissue) | 0.062 ± 0.013 | Synergistic |
Oxidative stress markers | ||
Lipid peroxidation (pmol/g tissue) | 0.641 ± 0.050 | Synergistic |
GSH (mg/g tissue) | 0.864 ± 0.019 | Synergistic |
TAC (μg BHT Eq/g tissue) | 0.969 ± 0.136 | Synergistic |
SOD (IU/mg protein) | 0.624 ± 0.144 | Synergistic |
GPX (IU/mg protein) | 0.655 ± 0.099 | Synergistic |
Catalase (IU/mg protein) | 0.7663 ± 0.162 | Synergistic |
GST (IU/mg protein) | 1.1262 ± 0.226 | Antagonistic |
GST α1 (expression fold) | 1.814 ± 0.600 | Antagonistic |
Inflammatory parameters | ||
NO (mmol/g tissue) | 0.677 ± 0.119 | Synergistic |
IL-6 (pg/g tissue) | 0.402 ± 0.100 | Synergistic |
DNA fragmentation (%) | 0.844 ± 0.084 | Synergistic |
*CI value of < 1 shows synergistic effect; > 1 shows antagonistic effect; = 1 shows additive effect. TAC Total antioxidant capacity, HCA Hydroxycinnamic acid, ABTS 2,2- azino-bis(3-ethylbenzthiazoline-6-sulfonic acid, BHT Butylated hydroxytoluene, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ALP Alkaline phosphatase, GSH Reduced Glutathione, SOD Superoxide dismutase, GPX Glutathione peroxidase, GST Glutathione S-transferase, NO Nitric oxide, IL-6 Interleukin-6